The members of the Management and Therapy Subcommittee undertook an evidence-
based review of current dry eye therapies and management options. Management options …

Dry eye disease (DED) is a frequently observed eye complaint, which has recently attracted
considerable research interest. Conventional therapy for DED involves the use of artificial …

Dry eye disease (DED) is the most common ocular surface disease, characterized by
insufficient production and/or instability of the tear film. Tear substitutes are usually the first …

Dry eye can damage the ocular surface and result in mild corneal epithelial defect to
blinding corneal pannus formation and squamous metaplasia. Significant progress in the …

Dry eye disease (DED) is a growing public health concern affecting quality of life and visual
function, with a significant socio-economic impact. It is characterised by the loss of …

Purpose: The purpose of this article is to review the evidence for the hypothesis that the core
mechanism of dry eye disease (DED) is inflammation, including evidence from recent basic …

Context A variety of topical and systemic drugs are available to treat primary Sjögren
syndrome, although no evidence-based therapeutic guidelines are currently available …

Nutrients, required by human bodies to perform life-sustaining functions, are obtained from
the diet. They are broadly classified into macronutrients (carbohydrates, lipids, and proteins) …

Background Topical cyclosporine A (also known as ciclosporin A)(CsA) is an anti‐
inflammatory that has been widely used to treat inflammatory ocular surface diseases. Two …

Dysfunctional tear syndrome (DTS) is a common and complex condition affecting the ocular
surface. The health and normal functioning of the ocular surface is dependent on a stable …